Company news

PureTech Health PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

New Sonde Study: Vocal Biomarkers for Respiratory

May 23, 2023

Vedanta Fast Track Designation & Ph2 Data at DDW

May 9, 2023

Akili Trial Results of EndeavorRx in Adults w/ADHD

May 4, 2023

PRTC Final Results & Publication of Annual Report

April 28, 2023

Vedanta Gets $106M+ to Advance Microbiome Pipeline

April 25, 2023

Vedanta Publishes VE303 Phase 2 Results in JAMA

April 17, 2023

PRTC Gets Up To $500M From RPRX For KarXT Royalty

March 23, 2023

Karuna 2nd Successful Ph3 Study in Schizophrenia

March 20, 2023

PureTech to Present at Barclays Healthcare Conf

March 1, 2023

Sonde & MGH Lead Study on Frontotemporal Disorders

February 27, 2023

PRTC Plans Ph2a trials w/ LYT-300 in PPD/Anxiety

February 14, 2023

PureTech to Present at SVB Global Biopharma Conf.

February 1, 2023

AKLI Positive ADHD Pivotal Data in Kids 13-17 yrs

January 6, 2023

PRTC Provides Recap Ahead of Catalyst-Rich 2023

December 22, 2022

LYT-300 Shows Proof of Principle in Clinical Trial

December 19, 2022

PureTech to Present at J.P. Morgan HC Conference

December 13, 2022

PRTC Leukemia Data at ASH & Begins AML Trial

December 12, 2022

Sonde Gets $19M+ for Voice-Based Health Monitoring

December 9, 2022

Vor Announces AML Clinical Data + Raises $115M

December 7, 2022

PRTC's New Candidate: Oral CBD for Epilepsy/CNS

November 30, 2022

PRTC Presents at Two Upcoming Investor Conferences

November 17, 2022

Gelesis Presents New Data at ObesityWeek 2022

November 2, 2022

PRTC to Present at Credit Suisse Healthcare Conf

November 1, 2022

Offer Talks Terminated

October 11, 2022

PureTech Health plc

October 10, 2022

PRTC to Present at Morgan Stanley Healthcare Conf

September 8, 2022

PRTC LYT-100 Data & IPF Trial Design at ERS Conf

September 5, 2022

GLS Data: Candidate Improved Insulin Sensitivity

August 25, 2022

PRTC's Sonde Partners with Koye Pharmaceuticals

August 24, 2022

PRTC's Akili to Debut on Nasdaq

August 22, 2022

PRTC Receives $115M from Founded Entity Shares

August 9, 2022

Karuna Successful Ph3 KarXT Study in Schizophrenia

August 8, 2022

Akili/Shionogi Begin Ph3 ADHD Study in Japan

August 1, 2022

New Akili Data in Lupus: Better Function in Adults

July 14, 2022

PRTC's Akili Announces Public Company BOD Nominees

July 11, 2022

PRTC Starts LYT-100 IPF Study & Advances LYT-200

June 30, 2022

PRTC's Vedanta Unveils New Manufacturing Facility

June 28, 2022

GLS: New $15M Plenity Pre-Paid Order; $55M Total

June 21, 2022

LYT-300 Achieves Proof-of-Principle in Human Study

June 14, 2022

Post-Acute COVID Resp. Complications Topline Data

June 14, 2022

Akili Adds Another Life Sciences Vet to C-Suite

June 6, 2022

GLS Data at ADA: Metabolic Benefits & Gut Bacteria

June 6, 2022

Akili & Roblox (NYSE: RBLX) Partner on EndeavorRx

May 26, 2022

PRTC's Vedanta Presents Data at DDW Annual Meeting

May 24, 2022

PRTC to Present at UBS Healthcare Conference

May 17, 2022

PRTC Presents LYT-100 Data at ATS Conference

May 16, 2022

PRTC Share Buyback Programme Commences Purchases

May 9, 2022

PRTC Announces Share Buyback Programme Up to $50M

May 5, 2022

Gelesis Presents GS200 Weight Loss Data at ECO

May 4, 2022

Gelesis Data: Therapeutic Shows Gut Health Benefit

April 29, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 6 calls. Every call is listed under its year.

Decks

The 5 newest of 7 decks. Every deck is listed under its year.